Clive Morris (Inivata Ltd.)

Morris, Clive (Inivata 201807–202205 CEO before CMO joined 201605 before AstraZeneca LEFT 5/22)

	Organisation	Inivata Ltd.
	Group	NeoGenomics (Group)
	Former/major organisation	AstraZeneca plc (LSE/STO/Nasdaq: AZN)
	Group	AstraZeneca (Group)
	Product	liquid biopsy
	Product 2	drug discovery

Record changed: 2022-05-24

Picture Berlin Partner bio:cap Investival Life Science AI 650x200px

More documents for Clive Morris

[1] NeoGenomics, Inc.. (5/9/22). "Press Release: NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary". Ft. Myers, FL....
[2] Inivata Ltd.. (4/28/21). "Press Release: Inivata and Agendia Sign Agreement for Commercialization of RaDaR MRD Liquid Biopsy Assay in Breast Cancer". Research Triangle Park, NC, Cambridge, Irvine, CA & Amsterdam....
[3] Inivata Ltd.. (3/9/21). "Press Release: FDA Grants Breakthrough Device Designation for Inivata’s RaDaR Assay". Research Triangle Park, NC & Cambridge....
[4] Inivata Ltd.. (2/4/21). "Press Release: Inivata Raises $35 million in Second Close of Series C Financing". Research Triangle Park, NC & Cambridge....
[5] Inivata Ltd.. (9/22/20). "Press Release: Inivata Appoints Peter Collins as Chief Business Officer". Research Triangle Park, NC & Cambridge....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com